LA CaTS Center Research Parter, LSU Health Shreveport, is one of the first centers in the country to enroll patients into an international study testing whether inhaled nitric oxide improves outcomes in COVID-19 patients with lung damage. See links to various news articles below for more information.

Shreveport Times: Newsroom: